Hoffnung stirbt zum Schluss...!

www.plainsite.org/flashlight/index.html?id=1374531

www.nasdaq.com/article/...s-reverse-stock-split-20140113-00015

(RTTNews.com) - A.P. Pharma, Inc. (APPA.OB), a specialty pharmaceutical company, announced Monday that it has changed its name to Heron Therapeutics, Inc. and effected a 1-for-20 reverse stock split, both effective January 13.


The company noted that the reverse split is being implemented to increase its stock price in support of its pending application to list on the NASDAQ Capital Market. The company expects to list on NASDAQ by the end of January. The company's trading symbol will be "APPAD" for up to 20 trading days after the split to designate that it is trading on a post-reverse split basis. Upon listing on NASDAQ, the trading symbol will change to "HRTX".

In addition, the company announced the appointment of three new independent directors, effective today. They are John Poyhonen, President and Chief Executive Officer of Senomyx, Inc., Kimberly Manhard, Senior Vice President of Regulatory Affairs and Development Operations at Ardea Biosciences, a subsidiary of AstraZeneca PLC, and Craig Johnson, a senior advisor and consultant in the biopharma industry.

Regarding the appointments, Barry Quart, PharmD, Chief Executive Officer of Heron Therapeutics, said, "2014 promises to be a landmark year for Heron. As we advance our lead drug candidate, Sustol, toward a planned commercial launch, advance our post-operative pain program to clinical studies and further exploit our polymer-based platform, the combined operations, strategic and financial expertise of these veterans will be invaluable."

Heron Therapeutics' lead product candidate, Sustol - formerly known as APF530, is being developed for the prevention of both acute- and delayed-onset chemotherapy-induced nausea and vomiting or CINV.


Read more: www.nasdaq.com/article/...k-split-20140113-00015#ixzz2wyyGfLW4

--------------------------------------------------

3/30/2012 Tang Capital Partners, LP Assignee Trademark 2990378  

--------------------------------------------------

3/30/2012 Tang Capital Partners, LP Assignee Application 78272784  

--------------------------------------------------

3/30/2012 Tang Capital Partners, LP Assignee Trademark 2953588  

--------------------------------------------------

3/30/2012 Tang Capital Partners, LP Assignee Application 78291878  

--------------------------------------------------

3/30/2012 Tang Capital Partners, LP Assignee Trademark 3142863  

--------------------------------------------------

3/30/2012 Tang Capital Partners, LP Assignee Application 78291884  

--------------------------------------------------

3/30/2012 Tang Capital Partners, LP Assignee Trademark 3126325  

--------------------------------------------------

3/30/2012 Tang Capital Partners, LP Assignee Application 78681899  

--------------------------------------------------

3/30/2012 Tang Capital Partners, LP Assignee Trademark 3129297  

--------------------------------------------------

3/30/2012 Tang Capital Partners, LP Assignee Application 78681906  

--------------------------------------------------

3/30/2012 Tang Capital Partners, LP Assignee Trademark 3185099  

--------------------------------------------------

3/30/2012 Tang Capital Partners, LP Assignee Application 78733588  

--------------------------------------------------

3/30/2012 Tang Capital Partners, LP Assignee Trademark 3217230  

--------------------------------------------------

3/30/2012 Tang Capital Partners, LP Assignee Application 78733592  

--------------------------------------------------

3/30/2012 Tang Capital Partners, LP Assignee Trademark 3117066  

--------------------------------------------------

3/30/2012 Tang Capital Partners, LP Assignee Application 78681919  

--------------------------------------------------

3/30/2012 Tang Capital Partners, LP Assignee Trademark 3117067  

--------------------------------------------------

3/30/2012 Tang Capital Partners, LP Assignee Application 78681923  

--------------------------------------------------

3/30/2012 Tang Capital Partners, LP Assignee Trademark 2979018  

--------------------------------------------------

3/30/2012 Tang Capital Partners, LP Assignee Application 78274235  

--------------------------------------------------

11/14/2011 Tang Capital Partners, LP Assignee Trademark 2817880  

--------------------------------------------------

11/14/2011 Tang Capital Partners, LP Assignee Application 76240253  

--------------------------------------------------

11/14/2011 Tang Capital Partners, LP Assignee Trademark 2841752  

--------------------------------------------------

11/14/2011 Tang Capital Partners, LP Assignee Application 78179744  

--------------------------------------------------

11/14/2011 Tang Capital Partners, LP Assignee Trademark 1623172  

--------------------------------------------------

11/14/2011 Tang Capital Partners, LP Assignee Application 74008219  

--------------------------------------------------

11/14/2011 Tang Capital Partners, LP Assignee Trademark 2179179  

--------------------------------------------------

11/14/2011 Tang Capital Partners, LP Assignee Application 75148647  

--------------------------------------------------

11/14/2011 Tang Capital Partners, LP Assignee Trademark 2990378  

--------------------------------------------------

11/14/2011 Tang Capital Partners, LP Assignee Application 78272784  

--------------------------------------------------

11/14/2011 Tang Capital Partners, LP Assignee Trademark 2953588  

--------------------------------------------------

11/14/2011 Tang Capital Partners, LP Assignee Application 78291878  

--------------------------------------------------

11/14/2011 Tang Capital Partners, LP Assignee Trademark 3142863  

--------------------------------------------------

11/14/2011 Tang Capital Partners, LP Assignee Application 78291884  

--------------------------------------------------

11/14/2011 Tang Capital Partners, LP Assignee Trademark 3126325  

--------------------------------------------------

11/14/2011 Tang Capital Partners, LP Assignee Application 78681899  

--------------------------------------------------

11/14/2011 Tang Capital Partners, LP Assignee Trademark 3129297  

--------------------------------------------------

11/14/2011 Tang Capital Partners, LP Assignee Application 78681906

www.businesswire.com/news/home/...s-Update-Sustol-Resubmission

our partner?!



REDWOOD CITY, Calif.--(BUSINESS WIRE)--Heron Therapeutics, Inc. (NASDAQ: HRTX), a specialty pharmaceutical company, today announced an approximate one-quarter delay to the Company’s timeline for the resubmission of the new drug application (NDA) for Sustol®

Heron Therapeutics (formerly A.P. Pharma, Inc.) is a specialty pharmaceutical company developing products using its proprietary Biochronomer™ polymer-based drug delivery platform.

die kauf-verkauf der aKtien bei dem Minimum und  in der letzten Zeit

finance.yahoo.com/...s?s=HRTX+Interactive#symbol=HRTX;range=my

Versuch dein Glück aber das gehört nicht hier her.  

yahoo.brand.edgar-online.com/...mpanyid=876&formtypeID=338


Received ( Period )  



SC 13D/A



HERON THERAPEUTICS, INC. /DE/(AP PHARMA INC /DE/) (TANG CAPITAL PARTNERS LP)

11/22/13



SC 13D/A



HERON THERAPEUTICS, INC. /DE/(AP PHARMA INC /DE/) (TANG CAPITAL PARTNERS LP)

05/09/13



SC 13D/A



HERON THERAPEUTICS, INC. /DE/(AP PHARMA INC /DE/) (TANG CAPITAL PARTNERS LP)

07/30/12



SC 13D/A



HERON THERAPEUTICS, INC. /DE/(AP PHARMA INC /DE/) (TANG CAPITAL PARTNERS LP)

05/11/12



SC 13D/A



HERON THERAPEUTICS, INC. /DE/(AP PHARMA INC /DE/) (TANG CAPITAL PARTNERS LP)

07/07/11



SC 13D/A



HERON THERAPEUTICS, INC. /DE/(AP PHARMA INC /DE/) (BAKER FELIX)

07/07/11



SC 13D/A



HERON THERAPEUTICS, INC. /DE/(AP PHARMA INC /DE/) (TANG CAPITAL PARTNERS LP)

05/03/11



SC 13D/A



HERON THERAPEUTICS, INC. /DE/(AP PHARMA INC /DE/) (BAKER FELIX)

05/03/11



SC 13D/A



HERON THERAPEUTICS, INC. /DE/(AP PHARMA INC /DE/) (TANG CAPITAL PARTNERS LP)

06/03/10



SC 13D/A



HERON THERAPEUTICS, INC. /DE/(AP PHARMA INC /DE/) (TANG CAPITAL PARTNERS LP)

10/26/09



SC 13D/A



HERON THERAPEUTICS, INC. /DE/(AP PHARMA INC /DE/) (TANG CAPITAL PARTNERS LP)

02/18/09



SC 13D/A



HERON THERAPEUTICS, INC. /DE/(AP PHARMA INC /DE/) (TANG CAPITAL PARTNERS LP)

12/29/08



SC 13D/A



HERON THERAPEUTICS, INC. /DE/(AP PHARMA INC /DE/) (TANG CAPITAL PARTNERS LP)

11/24/08



SC 13D/A



HERON THERAPEUTICS, INC. /DE/(AP PHARMA INC /DE/) (TANG CAPITAL PARTNERS LP)

11/10/08



SC 13D/A



HERON THERAPEUTICS, INC. /DE/(ADVANCED POLYMER SYSTEMS INC /DE/) (JOHNSON & JOHNSON)

03/12/98

sehr bald auch

SEC Accession No. 0001214659-13-000786



Filing Date

2013-02-14

Accepted

2013-02-14 08:03:04

Documents

1


Filing Date Changed

2013-02-14


Group Members

KEVIN C. TANGTANG CAPITAL MANAGEMENT LLC




Document Format Files



Seq

Description

Document

Type

Size



1

AMENDMENT NO. 4

c213134sc13ga4.htm

SC 13G/A

133168





Complete submission text file

0001214659-13-000786.txt



134774



Mailing Address 200 CONNELL DRIVE.. BERKELEY HEIGHTS NJ 07922

Business Address 200 CONNELL DRIVE.. BERKELEY HEIGHTS NJ 07922 (908) 286-9800

GENTA INC DE/ (Subject) CIK: 0000880643 (see all company filings)
IRS No.: 330326866 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-42004 | Film No.: 13606308
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1



Mailing Address 4747 EXECUTIVE DRIVESUITE 510 SAN DIEGO CA 92121

Business Address 4747 EXECUTIVE DRIVESUITE 510 SAN DIEGO CA 92121 858-200-3830

TANG CAPITAL PARTNERS LP (Filed by) CIK: 0001191935 (see all company filings)
IRS No.: 680517277 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

alles vorbereitet um tons von Geld zu verdienen, hin und zurueck
Rechte von Patenten und von der neuen Firma-Genta
Hoffentlich koennen sie auch fuer die Welt was machen.tesetaxel bleibt immernoch mit der besten Wirkung in der Welt

$$$

eine Firma, die alles uebernimmt zum ueberleben?Natuerlich, also Heron und Tango Capital haben fast alle Rechte fuer die Patenten.ist Heroneine Firma die in der Boerse handelt?natuerlich.Ist Tango eine Firma, die fast alle Notes von den beiden Firmen gekauft hat?Natuerlich

ich verstehe nicht wieso die neue Adresse von Genta ist diese:
Genta Inc.
3550 General Atomics Court
San Diego, CA 92121
www.ga.com/

noch mal San Diego, wer befindet sich in San Diego?Tang Capital

United States Trademark and Trademark Office, Trademark Assignment 5124/652:
Assigns The Entire Interest

No tags have been applied so far. Sign in to add some.
   

Assignor
 Assignee

Genta Inc.
Paperwork Executed September 30, 2013

10/11/2013 Gfv, LLC Assignee Trademark 2817880  

--------------------------------------------------

10/11/2013 Gfv, LLC Assignee Application 76240253  

--------------------------------------------------

10/11/2013 Gfv, LLC Assignee Trademark 2841752  

--------------------------------------------------

10/11/2013 Gfv, LLC Assignee Application 78179744  

--------------------------------------------------

10/4/2013 Genta Inc. Assignor Trademark 2817880  

--------------------------------------------------

10/4/2013 Genta Inc. Assignor Application 76240253  

--------------------------------------------------

10/4/2013 Genta Inc. Assignor Trademark 2841752  

--------------------------------------------------

10/4/2013 Genta Inc. Assignor Application 78179744

United States Trademark and Trademark Office, Trademark Assignment 5129/509:
Change Of Name

No tags have been applied so far. Sign in to add some.
   

Assignor
 Assignee

Heron Therapeutics, LLC
Paperwork Executed October 2, 2013


Recorded
October 11, 2013

Gfv, LLC

Gfv, LLC
4747 Executive Drive, Suite 510
C/o Tang Capital Partners, Lp
San Diego, CA 92121

www.plainsite.org/flashlight/index.html?id=5364381

10/4/2013 Gfv, LLC Assignee Application 13170830 Taxane Compounds, Compositions And Methods  

--------------------------------------------------

10/4/2013 Gfv, LLC Assignee Publication 20120004429 Taxane Compounds, Compositions And Methods  

--------------------------------------------------

10/4/2013 Gfv, LLC Assignee Application 13455455 Taxane Compounds, Compositions And Methods  

--------------------------------------------------

10/4/2013 Gfv, LLC Assignee Publication 20120220634 Taxane Compounds, Compositions And Methods  

--------------------------------------------------

10/4/2013 Gfv, LLC Assignee Application 13426877 Gallium Complexes, Pharmaceutical Compositions And Metho...  

--------------------------------------------------

10/4/2013 Gfv, LLC Assignee Publication 20120245135 Gallium Complexes, Pharmaceutical Compositions And Metho...  

--------------------------------------------------

10/4/2013 Gfv, LLC Assignee Application 11551422 Pharmaceutical Gallium Compositions And Methods  

--------------------------------------------------

10/4/2013 Gfv, LLC Assignee Publication 20070105953 Pharmaceutical Gallium Compositions And Methods  

--------------------------------------------------

10/4/2013 Gfv, LLC Assignee Patent 7354952 Pharmaceutical Gallium Compositions And Methods  

--------------------------------------------------

10/4/2013 Gfv, LLC Assignee Application 12045997 Pharmaceutical Gallium Compositions And Methods  

--------------------------------------------------

10/4/2013 Gfv, LLC Assignee Publication 20080166296 Pharmaceutical Gallium Compositions And Methods  

--------------------------------------------------

10/4/2013 Gfv, LLC Assignee Patent 7456215 Pharmaceutical Gallium Compositions And Methods  

--------------------------------------------------

10/4/2013 Gfv, LLC Assignee Application 12046128 Pharmaceutical Gallium Compositions And Methods  

--------------------------------------------------

10/4/2013 Gfv, LLC Assignee Publication 20080160103 Pharmaceutical Gallium Compositions And Methods  

--------------------------------------------------

10/4/2013 Gfv, LLC Assignee Patent 7842724 Pharmaceutical Gallium Compositions And Methods  

--------------------------------------------------

10/4/2013 Gfv, LLC Assignee Application 07893374 Method Of Preparing 2'-o-methyl Cytidine Monomers Useful...  

--------------------------------------------------

10/4/2013 Gfv, LLC Assignee Patent 5606049 Method Of Preparing 2'-o-methyl Cytidine Monomers Useful...  

--------------------------------------------------

10/4/2013 Genta Inc. Assignor Application 13170830 Taxane Compounds, Compositions And Methods  

--------------------------------------------------

10/4/2013 Genta Inc. Assignor Publication 20120004429 Taxane Compounds, Compositions And Methods  

--------------------------------------------------

10/4/2013 Genta Inc. Assignor Application 13455455 Image Forming Apparatus, Image Carrier, And Process Cart...  

--------------------------------------------------

10/4/2013 Genta Inc. Assignor Publication 20120220634 Image Forming Apparatus, Image Carrier, And Process Cart...  

--------------------------------------------------

10/4/2013 Genta Inc. Assignor Application 13426877 Gallium Complexes, Pharmaceutical Compositions And Metho...  

--------------------------------------------------

10/4/2013 Genta Inc. Assignor Publication 20120245135 Gallium Complexes, Pharmaceutical Compositions And Metho...  

--------------------------------------------------

10/4/2013 Genta Inc. Assignor Application 11551422 Pharmaceutical Gallium Compositions And Methods  

--------------------------------------------------

10/4/2013 Genta Inc. Assignor Publication 20070105953 Pharmaceutical Gallium Compositions And Methods  

--------------------------------------------------

10/4/2013 Genta Inc. Assignor Patent 7354952 Pharmaceutical Gallium Compositions And Methods  

--------------------------------------------------

10/4/2013 Genta Inc. Assignor Application 12045997 Pharmaceutical Gallium Compositions And Methods  

--------------------------------------------------

10/4/2013 Genta Inc. Assignor Publication 20080166296 Pharmaceutical Gallium Compositions And Methods  

--------------------------------------------------

10/4/2013 Genta Inc. Assignor Patent 7456215 Pharmaceutical Gallium Compositions And Methods  

--------------------------------------------------

10/4/2013 Genta Inc. Assignor Application 12046128 Pharmaceutical Gallium Compositions And Methods  

--------------------------------------------------

10/4/2013 Genta Inc. Assignor Publication 20080160103 Pharmaceutical Gallium Compositions And Methods  

--------------------------------------------------

10/4/2013 Genta Inc. Assignor Patent 7842724 Pharmaceutical Gallium Compositions And Methods  

--------------------------------------------------

10/4/2013 Genta Inc. Assignor Application 07893374 Method Of Preparing 2'-o-methyl Cytidine Monomers Useful...  

--------------------------------------------------

10/4/2013 Genta Inc. Assignor Patent 5606049 Method Of Preparing 2'-o-methyl Cytidine Monomers Useful...

Kannst wieder schreiben. Aber noch mal so ein Spam dann sperre ich dich wieder.